跳至主要内容
临床试验/NCT03559231
NCT03559231Unknown不适用

Endoscopic Resection of Non-ampullary Duodenal Adenomas: Endoscopic Mucosal Resection (EMR) vs. Endoscopic Full-thickness Resection With the 'Duodenal Full-thickness Resection Device' (dFTRD)

Kliniken Ludwigsburg-Bietigheim gGmbH2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年5月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
2
主要终点
Complication Rate

研究概览

简要总结

Prospective, randomized multi-center trial. Comparison of Endoscopic Mucosal Resection (EMR) versus Endoscopic Full-Thickness Resection with the duodenal Full-Thickness Resection Device (dFTRD) of non-ampullary duodenal adenomas.

详细描述

Prospective, randomized multi-center trial. Comparison of Endoscopic Mucosal Resection (EMR) versus Endoscopic Full-Thickness Resection with the duodenal Full-Thickness Resection Device (dFTRD) of non-ampullary duodenal adenomas.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • duodenal adenoma
  • age 18 or older
  • written informed consent

排除标准

  • duodenal adenomas with a size > 25 mm
  • duodenal adenomas with 20 mm or less distance to the major and/or minor duodenal papilla
  • presence of two or more duodenal adenomas
  • suspected or histologically confirmed malignancy
  • tumor disease (exception: after successful curative treatment)
  • conditions/diseases of the upper GI-tract that impair advancing of the devices into the duodenum
  • moribund patient
  • pregnancy and breastfeeding
  • patients that cannot give informed consent (e.g. psychiatric disorders, language barrier,...)
  • other contraindications for duodenal resections

研究组 & 干预措施

dFTRD

Experimental

Endoscopic full-thickness resection of the duodenal adenoma with the 'duodenal Full-Thickness resection device' (dFTRD).

干预措施: dFTRD (Procedure)

EMR

Active Comparator

Endoscopic Mucosal Resection (EMR) of the duodenal adenoma (=standard therapy).

干预措施: EMR (Procedure)

结局指标

主要结局

Complication Rate

时间窗: 30 days

Composite endpoint of perforations and relevant bleeding

次要结局

  • Need of secondary surgical intervention(3 months)
  • 'R0'-Resection(within one week after resection (as soon as result of pathologic analysis of resected specimen is available))
  • Rate of 'en bloc' resections(within one week after resection (as soon as result of pathologic analysis of resected specimen is available))
  • Technical success(intraoperative)
  • Procedure time(30 days)
  • Duration of hospitalization(30 days)
  • number of patients with residual or recurrent duodenal adenoma at the follow-up endoscopy after 3 months(3 months)
  • number of necessary re-endoscopies(3 months)
  • number of patients with residual or recurrent duodenal adenoma at the follow-up endoscopy after 1 year(1 year)

研究者

发起方
Kliniken Ludwigsburg-Bietigheim gGmbH
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验